1. Deciphering the role of the PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis;Mills;Clinical Breast Cancer,2010
2. Exploiting the PI3K/AKT pathway for cancer drug discovery;Hennessy;Nat Rev Drug Discov,2005
3. Evolving strategies for overcoming resistance to HER2-directed therapy: Targeting the PI3K/Akt/mTOR pathway;O’Regan;Clinical Breast Cancer,2010
4. Targeting endocrine resistance: Is there a role for mTOR inhibition?;Johnston;Clinical Breast Cancer,2010
5. An integrative genomic and proteomic analysis of PI3KCA, PTEN, and AKT mutations in breast cancer;Stemke-Hale;Cancer Res,2008